Search

everythinglearnresearchcommunity

for

Search:↓

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Kindler Syndrome shows diverse symptoms and needs better diagnostic tools and care in resource-limited areas.

The luliconazole shampoo effectively reduces symptoms of seborrheic dermatitis and is well-tolerated.

Using adipose-derived stem cell media with minoxidil may help regrow hair in men with hair loss.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Diet can influence inflammatory skin diseases.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Abrus precatorius has medicinal benefits but can be toxic.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Itchy scalp is common, linked to various conditions, and hard to treat effectively.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Sweat hypersensitivity can cause severe skin issues in horses.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

A new compound shows promise as a topical treatment for hair loss.

The book is a detailed guide on hair diseases and diagnosis, useful for skin disease experts.

AP-1 controls tumor cell type by affecting key signaling pathways.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Overexpressing AVP1 and AtNHX1 in plants improves salt tolerance and root hair development.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.